Approval · Notice of Compliance 25018 · 2021
TISSUEBLUE: Notice of Compliance 25018
Issued January 15, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25018
- Date
- January 15, 2021
- Company
- Dutch Ophthalmic Research Center International BvZuidland, Zuid-Holland, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TISSUEBLUE | 02510995 | Marketed |
Medicinal ingredients
- BRILLIANT BLUE G 0.25 MG per ML